Antipsychotics and Aspiration Risk
Psychopharmacology and Psychiatry Updates
Release Date: 07/30/2025
Which Antidepressant Causes the Most Weight Gain?
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking research comparing weight gain across eight common antidepressants. Using data from 183,000 patients, this study finally provides concrete numbers to answer the question patients ask most: How much weight will I gain on this medication? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.
info_outline
Lisdexamfetamine for Binge Eating Disorder
Psychopharmacology and Psychiatry Updates
In this episode, we explore lisdexamfetamine as the first FDA-approved medication for binge eating disorder. Can one medication effectively treat both ADHD and binge eating simultaneously? We examine the evidence, duration of treatment, and strategies for addressing patient ambivalence in eating disorder pharmacotherapy. Faculty: Scott Crow, M.D. Host: Richard Seeber, M.D.
info_outline
Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking Swedish research on GLP-1 receptor agonists as a potential new treatment for alcohol use disorder. Could diabetes medications like semaglutide revolutionize addiction treatment where traditional therapies have fallen short? Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.
info_outline
Antidepressants vs. Anticonvulsants for Binge Eating
Psychopharmacology and Psychiatry Updates
In this episode, we explore pharmacotherapy for binge eating disorder, examining how antidepressants, anticonvulsants, and emerging treatments target different patient goals. Should your treatment focus on stopping binge episodes or achieving weight loss? We discuss evidence-based approaches to align medication choices with patient priorities for optimal outcomes. Faculty: Scott Crow, M.D. Host: Richard Seeber, M.D.
info_outline
Lithium Levels: Finding the Right Therapeutic Target
Psychopharmacology and Psychiatry Updates
In this episode, we explore the confusing world of lithium therapeutic levels with Dr. Paul Zarkowski. Why do different labs recommend different ranges for the same medication? We examine expert consensus on optimal dosing strategies for both acute treatment and maintenance therapy in bipolar disorder. Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.
info_outline
Antidepressants Beyond Depression: Applications in Bulimia Nervosa
Psychopharmacology and Psychiatry Updates
In this episode, we explore evidence-based pharmacotherapy for bulimia nervosa, including why higher doses of SSRIs work better than standard dosing, which medications to avoid completely, and how antidepressants can be effective even without depression being present. Why does fluoxetine require 60 mg daily for optimal results? Faculty: Scott Crow M.D. Host: Richard Seeber, M.D.
info_outline
Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking research on managing antipsychotic-induced weight gain through a comprehensive network meta-analysis. Could the combination of low-dose metformin and lifestyle modifications be the game-changer that helps patients maintain both mental stability and physical health? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.
info_outline
Monthly Injections, Long-Term Recovery: Naltrexone for OUD
Psychopharmacology and Psychiatry Updates
In this episode, we explore extended-release naltrexone for opioid use disorder, examining its unique role as a pure antagonist in patients who require safety-sensitive careers. How do we successfully navigate the challenging initiation period when patients must be opioid-free for a week? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outline
Antipsychotics and Aspiration Risk
Psychopharmacology and Psychiatry Updates
In this episode, we explore the surprising link between antipsychotic medications and pneumonia risk. Did you know that pneumonia is the fourth leading cause of death in schizophrenia patients, and certain medications increase this risk in unexpected ways? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.
info_outline
Buprenorphine, Methadone, and Naltrexone: Helping Patients with OUD Decide
Psychopharmacology and Psychiatry Updates
In this episode, we explore how to choose between methadone, buprenorphine, and naltrexone for opioid use disorder treatment. With over 100,000 overdose deaths annually, how do we match the right medication to save each patient's life? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outlineIn this episode, we explore the surprising link between antipsychotic medications and pneumonia risk. Did you know that pneumonia is the fourth leading cause of death in schizophrenia patients, and certain medications increase this risk in unexpected ways?
Faculty: Scott Beach, M.D.
Host: Richard Seeber, M.D.